Campbell & Co Investment Adviser’s Progyny PGNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-13,427
Closed -$228K 1292
2026
Q1
$228K Sell
13,427
-13,583
-50% -$291K 0.01% 940
2025
Q4
$694K Buy
27,010
+4,362
+19% +$100K 0.03% 707
2025
Q3
$487K Buy
+22,648
New +$515K 0.04% 742
2025
Q1
Sell
-10,233
Closed -$177K 1266
2024
Q4
$177K Sell
10,233
-299
-3% -$4.64K 0.01% 985
2024
Q3
$177K Sell
10,532
-15,999
-60% -$384K 0.01% 1024
2024
Q2
$759K Sell
26,531
-6,943
-21% -$209K 0.06% 482
2024
Q1
$1.28M Sell
33,474
-2,137
-6% -$80.8K 0.11% 294
2023
Q4
$1.32M Buy
35,611
+3,940
+12% +$132K 0.12% 262
2023
Q3
$1.08M Buy
31,671
+7,193
+29% +$272K 0.13% 242
2023
Q2
$963K Buy
+24,478
New +$883K 0.17% 161

Other funds holding PGNY

Campbell & Co Investment Adviser's PGNY Position: Q2 2026 in Review

Campbell & Co Investment Adviser sold out of Progyny (PGNY) in Q2 2026, closing a stake of 13,427 shares — an estimated $228K sold.

Campbell & Co Investment Adviser first reported a position in PGNY in Q2 2023 and held it in 10 quarters. The position peaked at $1.32M in Q4 2023. 118 funds tracked by Wall St. Rank hold PGNY as of Q2 2026.

  • Campbell & Co Investment Adviser reported no remaining Progyny position as of Q2 2026 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 13,427 Progyny shares in Q2 2026, an estimated $228K.
  • Campbell & Co Investment Adviser first reported a position in Progyny in Q2 2023 and held it in 10 quarters.
  • Campbell & Co Investment Adviser's Progyny position peaked at $1.32M in Q4 2023.
  • 118 funds tracked by Wall St. Rank held Progyny as of Q2 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.